Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lexicon Pharmaceuticals (LXRX) Income towards Parent Company: 2009-2011

Historic Income towards Parent Company for Lexicon Pharmaceuticals (LXRX) over the last 3 years, with Dec 2011 value amounting to -$33.8 million.

  • Lexicon Pharmaceuticals' Income towards Parent Company fell 47.16% to -$33.8 million in Q4 2011 from the same period last year, while for Dec 2011 it was -$115.1 million, marking a year-over-year decrease of 16.06%. This contributed to the annual value of -$116.2 million for FY2011, which is 14.19% down from last year.
  • Latest data reveals that Lexicon Pharmaceuticals reported Income towards Parent Company of -$33.8 million as of Q4 2011, which was down 29.66% from -$26.1 million recorded in Q3 2011.
  • Over the past 5 years, Lexicon Pharmaceuticals' Income towards Parent Company peaked at -$20.9 million during Q3 2009, and registered a low of -$33.8 million during Q4 2011.
  • In the last 3 years, Lexicon Pharmaceuticals' Income towards Parent Company had a median value of -$24.6 million in 2010 and averaged -$25.4 million.
  • Examining YoY changes over the last 5 years, Lexicon Pharmaceuticals' Income towards Parent Company showed a top increase of 5.12% in 2011 and a maximum decrease of 47.16% in 2011.
  • Lexicon Pharmaceuticals' Income towards Parent Company (Quarterly) stood at -$21.8 million in 2009, then declined by 5.43% to -$23.0 million in 2010, then slumped by 47.16% to -$33.8 million in 2011.
  • Its Income towards Parent Company was -$33.8 million in Q4 2011, compared to -$26.1 million in Q3 2011 and -$26.7 million in Q2 2011.